You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Bulgaria

Mar 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health market not significantly affected by recession

2011 was a successful year for consumer health in Bulgaria, in line with the unexpectedly high growth of Rx sales, despite the fact that the global recession has influenced Bulgaria as well as the US and most EU countries, and in spite of a second wave of recession in the EU in 2011. Progress was driven by the introductions of improved products and stronger marketing efforts on behalf of most major market players. The stability of the market was due to the performance of traditionally strong categories such as cough, cold and allergy remedies.

Advertising shapes much of consumers' spending

Advertising is the main method by which Bulgarian consumers become informed about current trends in consumer health and new products. Therefore, the most successful campaigns were those that educated consumers about the benefits of a particular category as a whole, such as emergency contraception, for example, rather than recommending one particular product. The drawback to consumers' heavy reliance on advertising is the relatively limited control over advertising content which allows some advertisers to make unsubstantiated claims about products of questionable quality, thereby misleading consumers.

Leading Bulgarian companies rely on exports as well as the domestic market

The Bulgarian consumer health market is highly fragmented with a small number of companies holding significant shares and an even smaller number of those being Bulgarian. Unless local players invest more in marketing and innovation their shares will continue to decline. This is likely to continue as the financial resources of local companies are limited in comparison with multinational players. In an attempt to ensure higher growth, many domestic manufacturers rely more and more on exporting their products to markets where Bulgarian products are traditionally well accepted, such as other Balkan countries and Russia. This approach has proved successful for most leading Bulgarian companies.

Chemists/pharmacies is the most important distribution channel

Distribution practices and habits changed little over the review period and chemists/pharmacies remained the key distribution channel for consumer health in Bulgaria. In spite of the numerous legal issues and legislation changes related to the operation of chemists/pharmacies, they were positively influenced by the overall retailing trends and became more focused on quality customer care. Parapharmacies/drugstores have started gaining popularity in Bulgaria but they cannot yet compete with chemists/pharmacies, and direct selling is losing popularity as its products have started to be perceived as being of lower quality and without qualified consultation available at the time of purchase.

Most consumer health categories are close to maturity

Consumer health is expected to perform well and register healthy growth over the forecast period but at a slower rate compared to the review period, since most of its categories are approaching maturity. Value sales will be driven up by increasing product variation and sophistication and likely new introductions in the few areas where the market is not yet fully mature. Other reasons for a possible slowdown over the next couple of years could be the global financial crisis and the EU crisis that followed, although Bulgaria is not as seriously affected by them as other countries in the EU.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Bulgaria with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Bulgaria, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Bulgaria for free:

The Consumer Health in Bulgaria market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Bulgaria?
  • What are the major brands in Bulgaria?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Bulgaria - Industry Overview

EXECUTIVE SUMMARY

Consumer health market not significantly affected by recession

Advertising shapes much of consumers' spending

Leading Bulgarian companies rely on exports as well as the domestic market

Chemists/pharmacies is the most important distribution channel

Most consumer health categories are close to maturity

KEY TRENDS AND DEVELOPMENTS

Chemists/pharmacies is the main sales channel for consumer health products

Marketing is driving the market forward but it needs stricter regulation

The market progressed relatively well in 2011

Some consumer health products are registered as foods in order to take advantage of less strict legislation and regulation

Weight management among the most successful categories due to sedentary lifestyles and poor diets

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

SOURCES

  • Summary 1 Research Sources

Consumer Health in Bulgaria - Company Profiles

Borola EOOD in Consumer Health (Bulgaria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Borola EOOD: Competitive Position 2011

Eurostok Bulgaria EOOD in Consumer Health (Bulgaria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Eurostok Bulgaria EOOD: Competitive Position 2011

Kendy Bulgaria OOD in Consumer Health (Bulgaria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Kendy Bulgaria OOD: Competitive Position 2011

Sopharma AD in Consumer Health (Bulgaria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Sopharma AD: Competitive Position 2011

Terrachim - Nikolay Kostov ET in Consumer Health (Bulgaria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Adult Mouth Care in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • The category generated 8% growth in current value terms in 2011. The limited popularity of OTC adult mouth care is due to a large extent to the intense competition from the beauty and personal care market, which offers more sophisticated products with multiple effects. Better distribution of beauty and personal care products combined with limited advertising and marketing of OTC products in the category further impedes the category's progress.

SWITCHES

COMPETITIVE LANDSCAPE

  • Tantum Verde remained the most popular adult mouth care brand in Bulgaria in 2011. Its share has been slowly declining over the review period, however, mainly because the company stopped investing in advertising. Hexoral by Johnson & Johnson Bulgaria EOOD was the second most popular product on the market in 2011.

PROSPECTS

  • The adult mouth care market is likely to be driven only by organic growth over the forecast period. Such growth is likely to be rather slow as adult mouth care is expected to reach maturity over the forecast period.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 14 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Systemic analgesics remain the most popular OTC analgesics type on the Bulgarian market, and the most popular product among them is Analgin, which has been a favourite of Bulgarians since its launch in 1954. Furthermore, for years it was the only systemic analgesic product on the market, therefore even when competitive products became available, Analgin remained the most often purchased among them.

SWITCHES

COMPETITIVE LANDSCAPE

  • Actavis EAD remained the market leader in 2011 with 23% of value sales. The second position was occupied by Sopharma AD with a value share of 20% and ownership of the most popular analgesics brand, Analgin.

PROSPECTS

  • Analgesics is among the most successful consumer health categories in terms of value sales, but as it is close to reaching maturity high growth rates are unlikely over the forecast period. In spite of the weakening positions of local manufacturers and intensive marketing campaigns by multinational companies, the local Analgin brand is expected to continue being the most popular analgesic as it is synonymous with pain relief for the majority of Bulgarians.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 20 Analgesics Company Shares by Value 2007-2011
  • Table 21 Analgesics Brand Shares by Value 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Sales of calming and sleeping products grew by 9% in current value terms in 2011. The best-sellers in the category were the popular Validol, Valerian and Glog-Menta-Valeriana brands. The use of calming and sleeping products was stimulated by the increasingly hectic lifestyles of Bulgarians combined with increased awareness of the damage that stress can cause to the body.

SWITCHES

COMPETITIVE LANDSCAPE

  • The market leader in 2011 was the Ukrainian company Farmak VAT with 41% of value sales through its Validol brand. The product has been present on the market for many years and its name is largely synonymous with calming and sleeping products. Its market share, however, has been in decline in recent years as the shares of products such as Valerol and Anervina grew due to the novelty of the products and the lack of marketing activities by Farmak VAT as the company relies on the traditional popularity of its leading brand.

PROSPECTS

  • Sales of calming and sleeping products are not expected to see dramatically high growth over the forecast period. Demand for calming and sleeping products will be stimulated by increasingly intense everyday lifestyles but as the category reaches maturity, and as more people turn to their doctors for advice on fighting stress (and doctors prescribe Rx medications), it is likely that growth will not be very significant.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 27 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • The Mucosolvan cough remedy was the most popular product in cough, cold and allergy remedies in 2011, followed by Fervex and Tylol Hot. All aforementioned products except Mucosolvan are cold remedies in the form of a hot drink, which has become the most popular form of cold and flu medication in Bulgaria. During the review period this form of cold remedy has gained stable market positions, competition between brands is intense and this form of cold treatment is threatening to occupy the leading positions where cough syrup has traditionally been a leader.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratoires UPSA is the leader in the Bulgarian market for cough, cold and allergy remedies in value terms with 17% share in 2011. Fervex and Tyrcine, which are among the most popular brands in cough, cold and allergy remedies, are the property of UPSA and among the main reasons for the company's good performance. Boehringer Ingelheim GmbH retained second position with 13% of value sales in 2011. GlaxoSmithKline Plc, Novartis Pharma Services AG (Bulgaria), Engelhard Arzneimittel GmbH & Co KG and Johnson & Johnson Bulgaria EOOD are the other major market players in the category.

PROSPECTS

  • Cough, cold and allergy remedies is expected to reach maturity by the end of the forecast period, as the time for educating consumers has passed and they have already established their habits and preferences. New players could be expected to enter the market but they would find it very difficult to fight the established positions of products which are already favourites among Bulgarians.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Sales of Decongestants by Category: Value 2006-2011
  • Table 33 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 34 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Due to increasingly hectic lifestyles, and healthy lifestyles still being perceived as “trendy” and not particularly essential, many Bulgarians still do not pay enough attention to their eating habits, which are traditionally poor: typically consisting of eating a big meal once or twice a day and also consuming large quantities of fast food and snacks. In spite of increasing disposable incomes and growing awareness, more hectic lifestyles and unbalanced diets have led to serious digestion problems, as well as weight issues.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Chinoin became the sector leader in 2010 and further strengthened its lead over Berlin Chemie AG in 2011 with a 16% value share versus 14% for Berlin Chemie. Actavis EAD was third with 13%.

PROSPECTS

  • The category growth is expected to continue over the forecast period. The reason for this is that the market is already reaching maturity. Furthermore, weight management products have become more and more popular in Bulgaria over the past couple of years, drawing attenton away from digestive remedies which are not well advertised, either at brand or category level. Many weight management products, on the other hand, are advertised as helping digestion as well as weight loss.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 42 Digestive Remedies Company Shares by Value 2007-2011
  • Table 43 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Ear care sales were stable in 2011 and even registered growth of 7% in current value terms. The review period as a whole has shown a relatively low level of sales due to the limited number of OTC products available on the market and the strong competition from Rx products. Consumers with ear problems avoid purchasing any product before consulting a doctor, who typically recommends Rx products.

SWITCHES

COMPETITIVE LANDSCAPE

  • The majority of the category's value sales in Bulgaria are taken by the local player Sopharma AD. Its share has grown to 82% in value terms in 2011. The remainder of the category is occupied by small companies and is quite fragmented. Ear care seems unattractive even for large multinational players and most prefer to develop Rx medicines which have greater potential for generating value sales, in line with consumers' preferences.

PROSPECTS

  • The expected growth of the category combined with its still low base indicate that its progress is most likely to remain insignificant by 2016. Consumers' habits are not likely to change unless market players invest in significant marketing efforts in order to make the category more popular and convince consumers that OTC ear care products deserve their attention, as much as Rx alternatives.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2006-2011
  • Table 47 Sales of Ear Care: % Value Growth 2006-2011
  • Table 48 Ear Care Company Shares by Value 2007-2011
  • Table 49 Ear Care Brand Shares by Value 2008-2011
  • Table 50 Forecast Sales of Ear Care: Value 2011-2016
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Bulgaria - Category Analysis

TRENDS

  • Emergency contraception sales grew by 11% in current value terms in 2011. This growth was driven by Escapelle, a product by the Hungarian company Richter Gedeon Ltd, launched in 2007. The launch was supported by an extensive marketing campaign, which included TV, radio, billboard and magazine advertisements and various sponsorships. This not only successfully popularised the product but also created consumer awareness of emergency contraception products and their usage and properties. The campaign is regularly maintained, thus ensuring sales growth.

CATEGORY DATA

  • Table 52 Sales of Emergency Contraception: Value 2006-2011
  • Table 53 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 54 Emergency Contraception Company Shares by Value 2007-2011
  • Table 55 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 56 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 57 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Eye care sales registered 8% growth in current value terms in 2011 but over the entire review period the category remained underdeveloped due to the strong competition from Rx eye care products. Local consumers rarely purchase consumer eye care products as they prefer to consult a doctor and take their recommendation for Rx eye care when they have a problem.

SWITCHES

COMPETITIVE LANDSCAPE

  • Galena as remained the Bulgarian eye care leader in terms of value sales with a 28% share in 2011. Johnson & Johnson Bulgaria EOOD occupied second position once again with 25% of value sales. The company gained its presence and good results in the category in 2007 following the acquisition of the popular Visine brand from Pfizer Laboratories Korea Ltd. All significant market players in the category are multinational.

PROSPECTS

  • The OTC eye care market is still underdeveloped and is likely to remain so over the forecast period. The main reason for this is that unlike Rx prescriptions, OTC products in this category are not considered necessary by consumers who prefer to stick to their doctors' recommendations of Rx products.

CATEGORY DATA

  • Table 58 Sales of Eye Care by Category: Value 2006-2011
  • Table 59 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 60 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 61 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 62 Eye Care Company Shares by Value 2007-2011
  • Table 63 Eye Care Brand Shares by Value 2008-2011
  • Table 64 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • The best-selling subcategory in herbal/traditional is dietary supplements. The mild effect of the herbal ingredients is preferred by consumers as dietary supplements are generally taken over the course of several weeks or even months.

COMPETITIVE LANDSCAPE

  • There were no notable new launches on the herbal/traditional products market in 2011 as manufacturers rely on the popularity of their existing products.

PROSPECTS

  • A CAGR of 5% in constant value terms is expected over the forecast period. Consumer awareness and health concerns, combined with the latest trends of using “bio” products, are the general factors that will shape the category’s performance.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 68 Herbal/Traditional Products Company Shares 2007-2011
  • Table 69 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care is yet to develop in Bulgaria and the category is far from maturity. There is quite a large portfolio of products for various needs but few of them are popular enough among consumers to have any significant influence on the market. Nizoral from Johnson & Johnson Bulgaria EOOD and Allergosan from Sopharma AD are the most popular brands in medicated skin care, and they retain their traditional popularity largely without significant marketing activities by their manufacturers. The popularity of these products is mainly due to the fact that they treat two of the most common skin problems, dandruff and general allergic reactions.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sopharma AD reclaimed the market leadership position in medicated skin care in 2011. The strong position of Sopharma AD is based almost entirely on the traditional popularity of its Allergosan brand. Johnson & Johnson Bulgaria EOOD ranked second with 21% of value sales in 2011, due to the popularity of its Nizoral brand. The rest of the category is fragmented between a large number of smaller players.

PROSPECTS

  • Although medicated skin care is not yet well developed in Bulgaria, the category is not expected to show any significant growth by 2016. Demand is expected to remain relatively low, mostly due to the intense competition from other categories in markets such as beauty and personal care which are better advertised and often cheaper, while at the same time claiming to treat the same issues as their medical counterparts.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 74 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 75 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 76 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 77 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids is among the least developed of the categories in the Bulgarian consumer health market. These products are largely neglected by potential consumers as the number of smokers in Bulgaria is among the highest in the EU, and many of them consider smoking more a freedom of choice that they do not wish to be deprived of, rather than an unhealthy habit. Active smokers currently make up almost one third of the Bulgarian population. Over the past couple of years, however, as health-consciousness began developing slowly among Bulgarians, especially among people with higher incomes living in major cities, an anti-smoking trend also became more visible which is likely to start altering the market landscape.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pharmacia Corp retained its leading position in the market in 2011 with its Nicorette brand. It was one of the first NRT smoking cessation aids to be launched on the Bulgarian market and remains traditionally popular among consumers. Novartis AG and Fertin A/S occupied the second and third positions, respectively. Currently there are no other significant players on the market as it is quite small and not attractive enough due to the still low sales levels.

PROSPECTS

  • Category growth is rather slow in 2011 but may show some signs of improvement in the forecast period. This was expected to be spurred by the mid-2010 ban on smoking in public; however this was postponed due to concerns from the foodservice industry that such a measure would cause a dramatic decline in the number of customers which in turn would exacerbate the effects of the global financial crisis for the Bulgarian tourism and foodservice industries. Instead of adopting a complete ban, the Bulgarian government started stricter regulation of premises with separate rooms for smokers and non-smokers. However, it is expected that in 2013 or by the end of the forecast period at the latest, a full ban will come into effect, although the habits of Bulgarian smokers are likely to change more slowly. On the other hand, as more Bulgarians become concerned about healthier lifestyles, it is possible that the number of smokers will start decreasing more significantly over the forecast period, hence the likely more significant growth for the 2012-2016 period.

CATEGORY INDICATORS

  • Table 78 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 79 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 80 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 81 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 82 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 83 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 84 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 85 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Imported brands are the most popular in sports nutrition in Bulgaria, with local producers very few in number and largely unknown. The number of consumers in the category remains limited but nonetheless, products of all formats and ingredients can be found on the market. Thus the sports nutrition market in Bulgaria is comparable to other EU countries. These products are further popularised by the increasing number of websites, which publish sports articles and balanced eating tips.

COMPETITIVE LANDSCAPE

  • Musashi, Nutrim and Biogame are among the category leaders because their products are well advertised, effectively distributed to key retail chains or fitness clubs and considered to be of premium quality.

PROSPECTS

  • Category value sales are expected to see a CAGR of 3% in constant terms over 2011-2016, a modest rate which is likely to be in line with the country's anticipated recovery from the financial crisis. Furthermore, the category is likely to generate sales due to increasingly hectic and sedentary lifestyles which will be the major driver of the popularity of fitness clubs and of sports nutrition as a consequence.

CATEGORY DATA

  • Table 86 Sales of Sports Nutrition: Value 2006-2011
  • Table 87 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 88 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 89 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Over the review period the Bulgarian vitamins and dietary supplements market grew quite quickly, due to increasing disposable incomes of Bulgarians and their growing concern for healthy lifestyles and illness prevention. Manufacturers responded to the growing demand by launching a large number of new products, aided by loose registration procedures and unrestricted advertising possibilities. This freedom has allowed some companies to launch vitamins and dietary supplements which do not have the qualities they claim. According to the Bulgarian authorities, most of them are simply harmless and there have been no serious accidents with such products due to strengthened controls.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Actavis EAD held 19% of category value sales in 2011. Walmark sro retained second position and the domestic manufacturer Kendy Bulgaria OOD was third in terms of 2011 value sales.

PROSPECTS

  • Consumer demands and preferences have changed over the review period, along with the category becoming more mature. More and more consumers pay special attention to the quality of the purchased products, and they are more likely to turn to higher-end and sophisticated vitamins and dietary supplements.

CATEGORY DATA

  • Table 90 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 91 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 92 Dietary Supplements by Positioning 2006-2011
  • Table 93 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 94 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 95 Vitamins Brand Shares by Value 2008-2011
  • Table 96 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 97 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 98 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Walmark sro and United Traders OOD have been competing in the last few years of the review period with their most popular products Clarinol 1000 and Regulavit, respectively. United Traders lost leadership in 2007 to Walwark, but then recovered it in 2008, before hanging on just in 2009, and then extending its lead over Walwark in 2010 and 2011. The company managed to retain its leading position in both 2010 and 2011.

COMPETITIVE LANDSCAPE

  • Weight management remains a highly fragmented category, with many small companies present and only a few distinct leaders. Walmark as and United Traders OOD are the leaders in terms of value sales. GM Pharma, Vita Gold OOD and Borola EOOD are the other major companies in weight management in Bulgaria.

PROSPECTS

  • Although the category is popular and performing well, a relative slowdown in sales is expected over the forecast period. Among the reasons for this likely to be the fact that some controversial products of lower quality are harming the category’s image and causing some consumers to turn to other forms of weight management, such as fitness. Major players in the category are expected to further stabilise their positions and gain share at the expense of small manufacturers and importers.

CATEGORY DATA

  • Table 99 Sales of Weight Management: Value 2006-2011
  • Table 100 Sales of Weight Management: % Value Growth 2006-2011
  • Table 101 Weight Management Company Shares 2007-2011
  • Table 102 Weight Management Brand Shares 2008-2011
  • Table 103 Forecast Sales of Weight Management: Value 2011-2016
  • Table 104 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Wound care showed good growth over the review period due to organic market growth and constant product diversification. However, the inconsistency of growth rates over the review period is an indication of the effect of the global financial crisis in recent years.

COMPETITIVE LANDSCAPE

  • Medica AD retained its leading position in the wound care market in 2011. The success of the company is due to its multiple brand strategy, with Cytoplast, Sanplast and Bandage Medika 5/10 having been available on the market for many years and being well known to consumers. Furthermore, the company constantly improves the properties of its products and maintains a high quality level. Laboratoires URGO SA was the other major player in wound care, occupying second place with a 16% share of value sales in 2011. The rest of the companies in the category are relatively small and each holds an insignificant share.

PROSPECTS

  • The category is not expected to see dynamic growth over the forecast period. Sticking plasters/adhesive bandages will form the backbone of the category throughout the forecast period while gauze, tape and similar products are expected to show higher constant value growth due to their low base. However, as a whole, the category is reaching maturity; therefore no significant growth is expected by 2016.

CATEGORY DATA

  • Table 105 Sales of Wound Care by Category: Value 2006-2011
  • Table 106 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 107 Wound Care Company Shares by Value 2007-2011
  • Table 108 Wound Care Brand Shares by Value 2008-2011
  • Table 109 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 110 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Microalgae
            • Saccharinum
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • L-Carnitine
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!